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Background: The study aims to evaluate the antibacterial and antibio-
film activities of Trigona honey (TH) in Malaysia against Streptococcus 
pneumoniae. 
Methods: The effect of TH on S. pneumoniae investigated using agar 
well diffusion, MIC, MBC, biofilm formation and RT-qPCR. 
Results: TH sample showed the larger zones of inhibition against S. 
pneumoniae, 22.2±0.4 at 100% concentration. TH possessed the 
lowest MIC, MBC, MIC50 and MIC90 against S. pneumoniae, 25%, 
30%, 12.5% and 25% (w/v) respectively. TH permeated established 
biofilms of S. pneumoniae, resulting in significant decreased the cells 
from the biofilm. RT-qPCR revealed that the expression of genes 
amiF, ftsY, mvaS, pnpA, argG, mvd1, purN, miaA and pbp2a were 
upregulated. While, glcK, marR, prmA and ccpA were downregula-
ted after exposure to honey.
Conclusion: Trigona honey demonstrated the highest antibacterial 
activity against S. pneumoniae at 100% of honey concentration. 
It has also shown that biofilm formation, and growth and survival 
of bacteria in biofilms is a complex process and require gene ex-
pression. 
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Introduction 
Streptococcus pneumoniae, an important human 
pathogen, is the most common cause for pneumo-
nia, meningitis, and otitis media [1]. Pneumococcal 
infections cause death for more than 1 million chil-
dren in the world per year, especially in developing 
countries [2]. Colonization of the nasopharyngeal 
niche is a commonality shared among S. pneumo-
niae, S. pyogenes, and S. aureus [3]. Biofilm pneu-
mococci display gene expression profiles similar to 
those of bacteria isolated from the lungs of mice; 
these profiles are distinct from planktonic bacte-
ria isolated from either blood or culture media [4]. 
Studies by Muñoz-Elías, (2008), Parker, (2009) and 
Trappetti, (2011) indicate that the genes required 
for robust biofilm formation in vitro are important 
for nasopharyngeal colonization and, in some ins-
tances, progression towards lung disease. In con-
trast, studies by Tapianen, (2008), Camilli, (2008) 
Lizcano, (2008) and Sanchez, (2008) reported no 
correlation between the ability of isolates to form 
robust biofilms in vitro and their virulence potential 
in humans and mice. Furthermore, Lizcano, (2008) 
reported that the ability to form early biofilms in 
vitro does not reflect virulence potential [5]. Anti-
biotic resistance is a serious problem worldwide, 
and it has made the search for new antimicrobial 
compounds more important [6]. Honey has been 
used as a traditional medicine for centuries [7]. 
Many in vitro studies have revealed antimicrobial 
activity of different honeys against a wide range 
of skin colonizing and food-borne bacterial spe-
cies, including antibiotic-resistant bacteria. Honey 
has beneficial actions against wound infections also 
in vivo [8], and licensed honey products are wi-
dely used in wound care [9]. Several properties in 
honey contribute to its antimicrobial activity. High 
osmolarity, low pH, and hydrogen peroxide are 
the main antimicrobial factors [10]. Also phenolic 
compounds may contribute to antimicrobial activity 
[11]. Many studies on antimicrobial activity of honey 
have been conducted in non-European countries 
[12]. However, it has been found that other honeys 
with different floral backgrounds exhibit equivalent 
inhibitory activity [13]. It is thus reasonable to search 
for new antimicrobial honey candidates from diffe-
rent parts of the world. TH is produced by  stin-
gless  bees without stings grown in uncultivated 
bushland in Malaysia and Indonesia. TH is generally 
brighter in appearance than ordinary forest honey 
and has a distinctive “bush” taste, i.e., a mixture 
of sweet and sour with a hint of fruity taste [14]. 
It has been reported that honey has more than 
100 distinct compounds with different biological 
functions [15], the main antibacterial compound 
in most types of honey is hydrogen peroxide [16]. 
However, perhaps the antibacterial activity of TH is 
due to phenolic compounds [17]. These compounds 
have non-sticky properties that could be used to 
control bacterial growth and biofilm formation [18]. 
In Malaysia, there are less available data on the 
therapeutic values of stingless bee Trigona honey 
against S. pneumoniae, especially at cellular and 
molecular levels, particularly on the virulence ge-
nes by using biofilm model. However, in this study, 
we tested the antibacterial and antibiofilm activities 
of TH against the important human pathogens S. 
pneumoniae.
Materials and Methods
Bacterial strains and culture conditions 
S. pneumoniae (ATCC 49619) was purchased from 
American type tissue culture (ATCC) and used 
throughout this study. The bacteria were grown 
routinely in TSB or on BHI agar plates supplemen-
ted with 5% (v/v) sheep blood at 37ºC in 5% CO2. 
Honey samples
Commercial Trigona honey (TH) samples were pur-
chased for the present study from Kelantan a state 
in East Coast of Peninsula Malaysia. Stock samples 
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100% were stored in the dark bottles, labelled ac-
cordingly and stored at room temperature away 
from light source. Then, honey samples have been 
prepared freshly for each experiment and syringe 
filter (pore size 0.45μm, diameter 25mm) was used 
in this study [19]. To ascertain the security of the 
purchased product, honey was presented to the bee 
hunters based on their geographical hunting area 
to identify the purity, reliability, and quality of the 
honey.
Agar well diffusion assay
Sterile distilled water was used to dilute TH to 
achieve 10%, 25%, 50%, and 75%, (w/v) concen-
tration of honey. A 4-5 colonies of S. pneumoniae 
were aseptically picked from the fresh culture plate 
using sterile cotton swab and then were suspended 
into 10 mL of saline solution and the inoculum was 
adjusted to be equal to 0.5 McFarland standard 
(1x108 CFU/ ml). A sterile cotton swab was then 
dipped into the bacterial suspension and streaked 
over the entire surface of plate for three times to 
ensure distribution. A sterile 9 mm cork borer (Fis-
her Scientific, UK) was used to create six wells of 
agar plate. The wells of agar plate were labelled 
and were added with 100 µL of the five diffe-
rent honey concentration; 10%, 25%, 50%, 75%, 
and 100% (w/v). The well with distilled water was 
used as a negative control. The agar plates were 
then incubated at 37 ºC for 24 hours. Ampicillin 
(10μg), ciprofloxacin (5μg) and tetracycline (30μg) 
were included to ascertain the reproducibility and 
reliability of the assay and the bacterial resistant 
profiles. Digital venire calliper was used to measu-
re the zones of inhibition [20-21]. The assay was 
carried out in triplicate 
Minimum inhibitory concentration
The MIC test was determined by using broth micro 
dilution method. Working bacteria culture was pre-
pared as previously described, adjusted to be equal 
to 0.5 McFarland standard (1x108 CFU/ ml) [20-21]. 
The concentrations of TH; 50%, 30%, 25%, 20%, 
12.5%, 10%, 6.3%, 5%, 3.1% and 1.6% (w/v) were 
freshly prepared for MIC. Initially, column number 1 
was filled with 100µl of inoculums with 50% con-
centration of honey, and the consecutive columns 
2 to 10 were filled with its corresponding concen-
tration (30%, 25%, 20%, 12.5%, 10%, 6.3%, 5%, 
3.1% and 1.6% (w/v) respectively). Column number 
11 was filled with 100µl of honey as a correspon-
ding negative control, and column number 12 was 
filled with 100µl of inoculum as a bacterial growth 
control. The plates were incubated at 37 °C for 24 
hours. After 24 hours, visually inspection was done. 
MIC value was identify by turbidity in the wells and 
were compared to the positive and negative controls 
[21-23]. Absorbance was measured by using the 
microtiter plate reader (Tecan Infinite 200 PRO, 
Austria) at 590 nm. The MIC50 and MIC90 was de-
termined by using the following formula:
Growth inhibition=
1-OD of bacterial growth control – OD of the test well x100
OD of bacterial growth control
Minimum bactericidal concentration
Minimum Bactericidal Concentration (MBC) was 
conducted using wells that appeared to have no 
growth (no turbidity) by visual inspection and were 
streaked onto nutrient agar plates using sterile 100μl 
loops. A sterile wire loop was gently and aseptically 
dipped into the non-turbidity selected wells before 
the bacteria were cultured on agar plate. The plates 
were labelled and incubated at 37ºC for 24 hours. 
Plate free of any bacterial growth was recorded as 
the MBC value [21].
Biofilm disruption
To determine whether TH affected biofilm biomass 
by facilitating the dissociation of adherent cells from 
the biofilm. Bacteria were grown in 96-well plate 
(Fisher Scientific, UK) for 24 hours at 37oC. After 
incubation, the liquid was discarded from each well, 
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biofilms were washed thrice with PBS to remove any 
planktonic cells, and TH over a range of concentra-
tions [0, 10, 20 and 40% (w/v), respectively] was 
added to the 24 hours established biofilms (Biofilms 
were tested by tube method and quantitative spec-
trophotometric method). Following the application 
of honey, bacterial cultures in the microtiter plate 
were incubated for a further 3 hours at 37oC as 
above and samples of the liquid above the biofilm 
were collected at 30 min intervals and optical densi-
ty was measured at 590nm using microplate reader 
[24].
Extraction of RNA from S. pneumoniae 
biofilms for RT-qPCR
Large scale, static biofilms of S. pneumoniae were 
grown in duplicate in 10 ml TSB medium (with 
20% honey for the ‘treated’ biofilms) in sterile petri 
dishes for 24 hours at 37oC, as for the small-scale 
biofilms. The liquid was aspirated and the biofilm 
was scraped from the surface of the Petri dish using 
a sterile cell scraper. Biofilms were resuspended in 
500 μl PBS and vortexed for 1 min to break up 
cell aggregates. Honey-treated and untreated cell 
suspensions were equilibrated (to approximately 
2.0×108 CFU/ ml) prior to treatment with muta-
nolysin 5μl and lysozyme 5μl for 15 minutes at 37 
oC. RNA extraction was carried out using the SV 
total RNA extraction kit (Promega, UK) according 
to the manufacturer’s instructions. RNA quantifi-
cation was performed by Bioanalyzer 2100 (Agi-
lent, USA). cDNA synthesis was carried out using a 
Reverse Transcriptase kit (Promega, UK) according 
to the manufacturer’s instructions. Briefly, tailing 
of RNA with a random primer was performed at 
70ºC for 5 minutes, annealing at 25ºC for 5 minu-
tes, extension at 37ºC for 1 hours and inactivation 
of samples at 70ºC for 15 minutes. Primers of S. 
pneumoniae were retrieved from previous studies 
as shown in Table 1 {Yadav, 2012 #86}. Lyophilised 
and desalted oligonucleotides were reconstituted 
using sterile ultrapure water. Oligonucleotides of 
S. pneumoniae were optimised and the efficien-
cies were tested prior to gene expression analysis. 
Optimal primers concentration were determined 
by qPCR of S. pneumoniae cDNA with a range of 
primer concentrations (100 nM to 400 nM). Densi-
tometry was performed using the Applied Biosys-
tems Step One Software v2.3. To determine the 
level of relative gene expression of S. pneumoniae 
samples, a modified 2-ΔΔ Ct method was used. 
All reactions were carried out in triplicate, and the 
expression of genes was analysed with reference 
to the expression of the housekeeping gene [25-
26]. (Table 1)
Statistical Analysis
Data was expressed as mean ± standard deviation. 
Independent student t-test from (SPSS version 20, 
2020) was used to compare between honey-trea-
ted and control groups. The significant was set at 
P<0.05.
Results
Inhibition of planktonic S. pneumoniae by TH
As shown in Table 2, agar well-diffusion assay shows 
the zone of inhibition for S. pneumoniae after trea-
ted with 100%, 75%, 50%, 25% and 10% (w/v) 
concentration of TH. TH exhibits greater inhibition 
on S. pneumoniae cultures The MIC of TH against 
S. pneumoniae was found to be 25% (w/v) and the 
MBC was found to be 30% (w/v). The MIC50 was 
found to be 12.5% (w/v) concentration of TH and 
MIC90 was found to be 25% (w/v) of TH against S. 
pneumoniae as shown in Figure 1 & Table 2.
S. pneumoniae biofilm development are inhi-
bited by sublethal concentrations of TH
When biofilms of S. pneumoniae were initiated in 
the presence of 10%, 20% and 40% (w/v) TH, a 
statistically significant reduction in biomass was ob-
served in each case. As shown in Figure 2, a reduc-
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Table 2. Determination of inhibition zone (mm).
Test organism
Concentration of TH
100% 75% 50% 25% 10%
S. pneumoniae 22.2±0.4 19.1±0.4 16.6±0.3 9.3±0.6 00.0±0.0
Mean ±standard deviation, n =3
Table 1. Gene specific primers of S. pneumoniae used for RT-qPCR analysis.
Gene name
Forward primer sequences Reverse primer sequences Amplicon size 
5’ → 3’ 5’ → 3’ bp
amiF GCTGAAAGCAAGGCTTGAGTA ACTTGTCGGTTGTTCGCTT 130
ftsY TCGAAAATTCTTTGGCCTGT ATCAAACGTGTTGTGCCAA 97
mvaS ATAGGGCAGTTCGTTGGTTG AGTGGAGCTGTGGCTGAGTT 103
pnpA TCGAGAAATTTGGTGCCTTT ACGAGTCCAAGCCATCTCAG 80
argG AAATCGCTTGGTTGGGATTA CACAAGCGTCAAGTCCTCAA 100
mvd1 GGCTATGCATGCTACGACAA CGAACAAAGTCCATAGCCTCA 84
purN TCCAGCCTACTTGCCAGAAT CCAGTGAATGGTCACACCAG 91
miaA GAGCGTATCAACCACCGAGT TAGGGGAATGGTCAAACAGC 82
pbp2a GGTGCAATTCCATTTTGCTT CGGTGCAGCTCATGTCTTTA 105
glcK TGAAAAAGGAGAATATGATGAGTCAA TGCAAATTTGATAGAAGTTCCAC 71
marR TGACCCCAAACAAAGAAGAC CCGCAATTTCCTTGTTGGTA 84
prmA ATGGAAACATGGCAAGAGTT GCTCCCAGCTCAATCAAGAG 83
ccpA GACAGGAAAAGGAATGAATGC GGAAACACCTGCTTCACGAG 70
gyrB* GATTTGGCGCAGAATTTGAT GTACGAATGTGGGCTCCATC 91
*: gyrB was used as a reference gene.
Figure 1:  Percentage of bacteria growth inhibition 
by Malaysian TH.
Figure 2:  The disruption of biofilm development 
using TH. 
Biofilms of S. pneumoniae were grown for 24 h in media supplemented 
with TH at 10%, 20% and 40% (w/v). Error bars show SEM.
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tion of 60% (P=0.03) was observed with 10% (w/ v) 
TH; 20 and 40% (w/v) TH resulted in between 80% 
(P=0.02) and 86% (P=0.01) reduction in biomass, 
respectively.
Gene expression of S. pneumoniae following 
treatment with TH
As shown in Table 3 and Figure 3, we performed 
RT-qPCR on 13 differentially expressed genes of S. 
pneumoniae. We calculated the fold-changes in 
gene expressions after normalization of each gene 
relative to the constitutively expressed gene gyrB 
after exposure to TH using the comparative thres-
hold method (22). 
Genes pnpA and purN encoding purine and 
pyrimidine nucleotide metabolism
Two genes (pnpA and purN) associated with ribo-
nucleotide biosynthesis in S. pneumoniae biofilms 
were increased 1.8 fold and 2.2-fold in gene expres-
sion respectively after treated with TH as shown in 
Table 3.
Genes mvaS and mvd1 encoding Isoprenoid 
metabolism
The two important isoprenoid metabolism pathway 
genes (mvaS and mvd1) were up regulated in S. 
pneumoniae biofilms. The fold increase in gene ex-
pression was 4.5 (P = 0.04) and 3.3 (P = 0.01) res-
pectively after exposure to TH as shown in Table 3.
Genes ccpA and marR encoding transcription 
regulatory protein
The two regulatory proteins encoding genes (ccpA 
and marR), were exclusively down regulated in bio-
film. ccpA and marR were down regulated by more 
two-fold (P < 0.05) as shown in Table 3.











detected by real- 
time RT-PCR
amiF Protein transport -1.00 2.00 2.0 0.03* 1.0
ftsY
SRP-dependent cotranslational protein 
targeting to membrane
-1.38 2.60 2.6 0.03* 0.6
mvaS Isoprenoid biosynthetic process -2.17 4.50 4.5 0.04* 0.9
pnpA RNA processing -0.85 1.80 1.8 0.02* 0.7
argG Arginine biosynthetic process -1.43 2.70 2.7 0.02* 0.8
mvd1 Isoprenoid biosynthetic process -1.72 3.30 3.3 0.01* 0.8
purN ‘de novo’ IMP biosynthetic process -1.14 2.20 2.2 0.01* 1.0
miaA tRNA processing -1.49 2.80 2.8 0.02* 1.0
pbp2a Cellular wall organization -1.38 2.60 2.6 0.03* 0.6
glcK Kinase activity 1.20 0.43 -2.3 0.02* 1.7
marR
Sequence-specific DNA binding 
transcription factor activity
2.00 0.25 -4.0 0.04* 2.0
prmA Protein methyltransferase activity 1.32 0.40 -2.5 0.02* 1.7
ccpA
Sequence-specific DNA binding 
transcription factor activity
1.43 0.37 -2.7 0.01* 1.8
*: Statistically significant change in the level expression compared treated with untreated and reference gene (P<0.05).
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Genes amiF, ftsY, argG, pbp2a, glcK and prmA 
encoding Transporter proteins
Six genes amiF, ftsY, argG, pbp2a, glcK and prmA 
were differentially regulated in biofilms S. pneumo-
niae. All genes were up regulated in biofilms except 
glcK and prmA were down regulated after exposure 
to TH as shown in Table 3 & Figure 3.
Discussion
Antibacterial activity of honey has been broadly dis-
cussed among researchers worldwide. MIC is the 
lowest concentration of honey solution required to 
inhibit 99.9 % of bacterial growth. MBC is defined 
as the lowest concentration of honey required to 
kill at least 99.9 % of the tested bacterial strains 
[21]. Previous studies showed that MIC and MBC 
for Manuka honey, Kelulut honey, Egyptian clover 
honey and Algerian honey against Pseudomonas 
aeruginosa were at 20% and 25% concentration 
of honey respectively [21, 23, 27-28]. Study by Ro-
berts et al., (2012) demonstrated that MIC and MBC 
for Manuka honey against P. aeruginosa were at 
12% and 16% concentration of honey respectively 
[29]. According to results in disruption, the trend of 
all concentrations of TH had disrupted biofilm for-
mation of S. pneumoniae, where the inhibition rate 
increased from 10% (w/v) honey concentration until 
reached to honey concentration of 40% (w/v). Pre-
vious studies demonstrated the ability of Manuka 
honey to disrupt preformed biofilms of S. pyogenes 
and P. aeruginosa [24, 29]. A study by Hammond 
et al., (2014) demonstrated that a dose–response of 
Manuka honey was able to reduced biofilm biomass 
of Clostridium difficile strains and the optimum Ma-
nuka honey activity occurred at 40-50% (v/v) [30]. A 
study by Eminek et al., (2017) showed that biofilms 
was developed over 3 days of E. coli and Proteus 
mirabilis culture and honey gave a dose-dependent 
reduction in biofilm formation (between 3.3 and 
16.7% w/v) [31]. A previous study reported that 
New Zealand, Cuba, and Kenya honeys were able 
to inhibit biofilm formation and to disrupt biofilms 
of S. aureus, P. aeruginosa and S. pyogenes [32]. 
The similarly or divergence of results might be due 
to several reasons such contain different level of 
active compounds including phenolic acids and fla-
vonoids [17, 33-34].
RT-qPCR was used to determine the level of 
gene expression of S. pneumoniae after treated 
Figure 3:  Gene expression profile in S. pneumoniae after being treated with TH.
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with TH. The overall expression pattern demons-
trated that more genes were up regulated in bio-
film after exposure to TH. The up regulation of 
peptidoglycan biosynthesis genes and ribosomal 
genes demonstrates that, in S. pneumoniae bio-
film, cells are growing and may be involved in 
protein synthesis for various processes. The down 
regulation of ribosomal protein genes in biofilm 
cells indicates that free-floating S. pneumoniae has 
reduced transcription capacity [35]. In this study, 
we used TSB medium supplied with 5% gluco-
se for biofilm growth with and without honey. 
Here, we detected up regulation of ribonucleoti-
de biosynthesis genes (pnpA and purN) in biofilm 
cells. Streptococcus mutans, PnpA is reportedly up 
regulated under stress conditions such as acidic 
pH, and is significant for cell viability and mRNA 
turn over in E. coli [36]. Our results suggest that 
biofilm cells are possibly under stress conditions 
and that stress-related genes are up regulated to 
support biosynthesis of new nucleic acid. The re-
cent discovery that diphosphomevalonate, an in-
termediate in the mevalonate pathway, potently 
and allosterically down regulates the activity of S. 
pneumoniae mevalonate kinase without inhibiting 
the human enzyme [37] provides an opportunity 
for developing a new class of antimicrobials that 
are capable of killing this bacterium without detri-
ment to the host. The finding of down regulation 
of three regulatory proteins encoding genes (ccpA, 
and marR) in biofilm cells after exposed to TH. 
S. pneumoniae adapts to changing growth con-
ditions through catabolite repression mediated by 
CcpA. In a previous study, CcpA was reported to be 
required for colonization of the nasopharynx and 
survival and multiplication in the lung [38]. MarR 
proteins regulate aromatic catabolism, expression 
of virulence factors and the response to antibiotic, 
antimicrobial stress and oxidative stress [39]. The 
transporter protein coding gene amiE are up regu-
lated in biofilms after treated. The amiF encode oli-
gopeptide ABC transporters, whose ATP-binding 
protein domains function in competence. Similar 
up regulation of amiF gene in meningitis bacteria 
has been reported [35]. The up regulation of this 
competence and peptide transporter gene indica-
tes that cells in biofilms may be involved in natural 
competence. Our study detected a few virulence 
and pathogenic genes whose expressions were 
up regulated and down regulated in in vitro early 
biofilms after adding honey. However, the gene 
expression patterns of most biofilm genes are clo-
se to previous gene expression reports in vivo [35] 
and in vitro [4]. This study reports a few genes that 
were down regulated to early in vitro biofilms after 
treatment with TH. Moreover, many studies have 
demonstrated strain-specific gene regulation in S. 
pneumoniae [40-41], gene expressions differing 
with the richness of growth media, bacteria see-
ding, and strain capsulation, factors which affect 
biofilm formation on microtiter plates [42-43]. 
In summary, honey is a complex substance esti-
mated to be comprised of between 200 and 600 
components, including fructose, glucose, sucrose 
and other sugars [44]. Additional minor constituents 
include acids, proteins, amino acids, nitrogen, and 
minerals. The antibacterial action of TH is attributed 
to its high osmolarity, low water activity, viscosity, 
low PH and the presence of hydrogen peroxide. The 
combination of these factors is thought to provide 
an unsuitable environment for bacterial growth. 
Conclusion 
According our best knowledge, this is the first stu-
dy investigated the level of gene expression of S. 
pneumoniae after exposure to TH. We conclude 
that the exclusive up regulation and down regu-
lation in genes involved in biofilms formation af-
ter treated with honey involved in the mevalonate 
pathway, cell wall biosynthesis, translation and pu-
rine and pyrimidine nucleotide metabolic pathway 
suggests that expression of these genes may be 
required for initial biofilm formation, and growth 
The InTernaTIonal arabIc Journal of anTImIcrobIal agenTs 
ISSN: 2174-9094
2021
Vol. 11 No. 2:1
doi: 10.3823/856
© Under License of Creative Commons Attribution 3.0 License 9
and survival of bacteria in biofilms. Our results in-
dicate that the TH might be used for antibacterial 
agents for treatment and modulation of infections 
caused by S. pneumoniae. 
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